论文信息 - Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. - 字舞流文

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

James R. Anderson | J. Gastier-Foster | J. Dome | P. Grundy | E. Perlman | P. Ehrlich | Yeonil Kim | Yueh-Yun Chi | R. Shamberger | J. Geller | N. Seibel | C. Fernandez | J. Kalapurakal | G. Khanna | M. Malogolowkin | D. Dix | E. Mullen | E. Gratias | Eric J. Gratias